ChemoCentryx Inc (CCXI)

10 top stocks to invest in for beginner investors

Hedge Fund and Insider Trading News: Hindsight Capital, Elliott Management, Third Point LLC, Skybridge Capital, Bandwidth Inc (BAND), ChemoCentryx Inc (CCXI), and More

Hindsight Capital’s 2020 Was Great. Wasn’t Yours? (Bloomberg) As the miserable year of 2020 has almost reached its end, it is time to return to the...

Keep Reading →

December 30 - Hedge Funds, Insider Trading - Comments

10 Best Low-Risk Stocks to Buy Right Now

Hedge Fund and Insider Trading News: Ray Dalio, Carl Icahn, Alden Global Capital, Cisco Systems, Inc. (CSCO), IDEX Corporation (IEX), and More

Billionaire Investor Ray Dalio Says Inviting Conflict is One of His Keys to Success (Business Insider) Billionaire investor Ray Dalio is one of the best...

Keep Reading →

November 28 - Hedge Funds, Insider Trading - Comments

Sio Capital Remains Bullish On These Stocks Despite Weak Performance

As a healthcare-focused fund, Michael Castor‘s Sio Capital registered a terrible 2016, as it lost 18.7% net, compared to the 12% gain registered...

Keep Reading →

March 3 - Hedge Fund Investor Letters, Hedge Funds, News - Comments

Healthcare-Focused Michael Castor Added These Stocks to His Portfolio Last Quarter

According to the latest 13F filing of Sio Capital, a global equity market healthcare hedge fund, the investment advisory has further increased its exposure...

Keep Reading →

September 27 - Hedge Fund Analysis, Hedge Funds, News - Comments

stock, exchange, trade, ipo, market, london, share, rate, sales, price, new, york, profit, index, broker, chart, rising, falling, street, frankfurt, wall, world, cash, points, display,

Here’s What You Should Know about These Five Advancing Stocks

US stocks are climbing on Tuesday on the back of a hike in oil prices, weakening Yen and China’s decision to boost its plunging exports, which pushed...

Keep Reading →

May 10 - Market Movers, News - Comments

Biotech-Focused Hedge Fund is Bullish on ChemoCentryx Inc (CCXI)

Tracking the activity of hedge funds via their filings with the Securities and Exchange Commission is particularly crucial, since these filings reveal...

Keep Reading →

September 17 - News - Comments

Neurocrine Biosciences, Inc. (NBIX), ChemoCentryx Inc (CCXI), Avanir Pharmaceuticals, Inc. (AVNR): Horrendous Health-Care Stocks Last Week

In a way, stocks go through seasons like the weather. Sometimes they spring forth, sometimes they’re hot like summer, sometimes they’re dormant...

Keep Reading →

September 16 - News - Comments

GlaxoSmithKline plc (ADR) (GSK), Inovio Pharmaceuticals Inc (INO), ISIS Pharmaceuticals, Inc. (ISIS): This Week in Biotech

With the SPDR S&P Biotech Index up 40% over the trailing-12-month period, it’s evident that investment dollars are willingly flowing into...

Keep Reading →

September 15 - News - Comments

AbbVie Inc (ABBV), GlaxoSmithKline plc (ADR) (GSK): Does ChemoCentryx Inc (CCXI) Have a Platform Problem?

It hasn’t been a fun month to be an investor in clinical-stage biotech ChemoCentryx Inc (NASDAQ:CCXI). After announcing at the end of August that...

Keep Reading →

September 11 - News - Comments

Do Hedge Funds and Insiders Love Sequenom, Inc. (SQNM)?

Is it smart to be bullish on Sequenom, Inc. (NASDAQ:SQNM)? If you were to ask many traders, hedge funds are seen as useless, outdated investment vehicles...

Keep Reading →

August 30 - News - Comments

Johnson & Johnson (JNJ), AbbVie Inc (ABBV), GlaxoSmithKline plc (ADR) (GSK): The Impact of a Failed Crohn’s Disease Trial Study

A small section of the total Crohn’s Disease) patient population is resistant to standard treatment options. Known as tumor necrosis factor-alpha...

Keep Reading →

August 29 - News - Comments

Hedge Funds Are Selling Emergent Biosolutions Inc (EBS)

To many investors, hedge funds are viewed as delayed, outdated financial vehicles of a forgotten age. Although there are more than 8,000 hedge funds with...

Keep Reading →

August 29 - News - Comments

ChemoCentryx Inc (CCXI), GlaxoSmithKline plc (ADR) (GSK): Horrendous Health-Care Stocks This Week

While many investors worried about the Nasdaq’s three-hour shutdown this week, shareholders of a few stocks probably wished it wouldn’t have...

Keep Reading →

August 26 - News - Comments

GlaxoSmithKline plc (ADR) (GSK), Johnson & Johnson (JNJ): ChemoCentryx Inc (CCXI) Collapses on Crohn’s Disease Results

Shares of small biotech ChemoCentryx Inc (NASDAQ:CCXI) collapsed by 44% in early trading on Friday before paring the losses somewhat. The huge sell-off...

Keep Reading →

August 23 - Dividend Stocks, News - Comments

ChemoCentryx Inc (CCXI): Hedge Funds Are Bullish and Insiders Are Bearish, What Should You Do?

ChemoCentryx Inc (NASDAQ:CCXI) was in 6 hedge funds’ portfolio at the end of March. CCXI has experienced an increase in enthusiasm from smart money...

Keep Reading →

July 15 - News - Comments

Should You Buy Protalix BioTherapeutics Inc. (PLX)?

Is Protalix BioTherapeutics Inc. (NYSEAMEX:PLX) undervalued? Prominent investors are betting on the stock. The number of long hedge fund positions improved...

Keep Reading →

July 8 - News - Comments

Sangamo Biosciences, Inc. (SGMO): Hedge Funds Are Bullish and Insiders Are Bearish, What Should You Do?

Is Sangamo Biosciences, Inc. (NASDAQ:SGMO) a buy here? Prominent investors are in an optimistic mood. The number of long hedge fund bets went up by 5...

Keep Reading →

July 8 - News - Comments

Posts Tagged ‘ChemoCentryx Inc (CCXI)’